K.-M. Alexacou

发表

New inhibitors of glycogen phosphorylase as potential antidiabetic agents.

S. Zographos, N. Oikonomakos, D. Leonidas, 2008, Current medicinal chemistry.

Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.

S. Zographos, N. Oikonomakos, D. Leonidas, 2009, Bioorganic & medicinal chemistry.

Crystallographic and computational studies on 4‐phenyl‐N‐(β‐D‐glucopyranosyl)‐1H‐1,2,3‐triazole‐1‐acetamide, an inhibitor of glycogen phosphorylase: Comparison with α‐D‐glucose, N‐acetyl‐β‐D‐glucopyranosylamine and N‐benzoyl‐N′‐β‐D‐glucopyranosyl urea binding

S. Zographos, N. Oikonomakos, D. Leonidas, 2007 .

Amide-1,2,3-triazole bioisosterism: the glycogen phosphorylase case

S. Zographos, N. Oikonomakos, D. Leonidas, 2009 .

Synthesis of new glycosyl biuret and urea derivatives as potential glycoenzyme inhibitors.

L. Somsák, M. Tóth, E. Chrysina, 2010, Carbohydrate research.

The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.

S. Zographos, N. Oikonomakos, D. Leonidas, 2010, Bioorganic & medicinal chemistry.

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

S. Zographos, N. Oikonomakos, D. Leonidas, 2008, Journal of medicinal chemistry.

N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.

S. Zographos, N. Oikonomakos, D. Leonidas, 2012, Bioorganic & Medicinal Chemistry.

Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.

S. Zographos, D. Leonidas, K. Kövér, 2014, Bioorganic & medicinal chemistry.

Halogen-substituted (C-β-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase.

S. Zographos, N. Oikonomakos, D. Leonidas, 2011, Bioorganic & medicinal chemistry.

FR258900, a potential anti‐hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase

S. Zographos, N. Oikonomakos, D. Leonidas, 2007, Protein science : a publication of the Protein Society.